SFM
CNCE
Sphera Funds Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,002,783
| Closed | -$5.86M | – | 93 |
|
|
2022
Q4 | $5.86M | Buy |
1,002,783
+50,000
| +5% | +$292K | 1.26% | 23 |
|
|
2022
Q3 | $6.38M | Buy |
952,783
+273,383
| +40% | +$1.83M | 0.89% | 32 |
|
|
2022
Q2 | $2.86M | Buy |
+679,400
| New | +$2.86M | 0.31% | 29 |
|
|
2021
Q1 | – | Sell |
-384,039
| Closed | -$4.85M | – | 201 |
|
|
2020
Q4 | $4.85M | Buy |
384,039
+74,039
| +24% | +$936K | 0.43% | 61 |
|
|
2020
Q3 | $3.04M | Sell |
310,000
-390,710
| -56% | -$3.84M | 0.3% | 67 |
|
|
2020
Q2 | $6.97M | Sell |
700,710
-312,329
| -31% | -$3.11M | 0.66% | 37 |
|
|
2020
Q1 | $8.96M | Buy |
1,013,039
+873,039
| +624% | +$7.72M | 1.12% | 17 |
|
|
2019
Q4 | $1.29M | Hold |
140,000
| – | – | 0.11% | 75 |
|
|
2019
Q3 | $823K | Buy |
+140,000
| New | +$823K | 0.13% | 70 |
|
|
2016
Q1 | – | Sell |
-180,000
| Closed | -$3.42M | – | 124 |
|
|
2015
Q4 | $3.42M | Sell |
180,000
-20,000
| -10% | -$379K | 0.5% | 39 |
|
|
2015
Q3 | $3.75M | Buy |
200,000
+184,142
| +1,161% | +$3.46M | 0.48% | 35 |
|
|
2015
Q2 | $236K | Sell |
15,858
-359,142
| -96% | -$5.34M | 0.02% | 120 |
|
|
2015
Q1 | $5.68M | Buy |
375,000
+225,000
| +150% | +$3.41M | 0.59% | 30 |
|
|
2014
Q4 | $2M | Buy |
150,000
+127,300
| +561% | +$1.7M | 0.34% | 86 |
|
|
2014
Q3 | $286K | Buy |
+22,700
| New | +$286K | 0.04% | 110 |
|